Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722770 · ClinicalTrials.gov registry record
Clinical Development of Deep Learning for the OtoSight
A clinical trial, sponsored by PhotoniCare.
- Completed
- Registry status
- 188
- Enrollment target
NCT04722770 is a clinical trial that has completed, run by PhotoniCare. The registered enrollment target is 188 participants.
The verdict
NCT04722770 has completed, sponsored by PhotoniCare.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
The objective of this study is to clinically develop and evaluate a machine learning approach to improve the performance and data interpretation of the PhotoniCare OtoSight Middle Ear Scope in pediatric patients presenting at the primary care office for suspected ear infections. In this observational study, results of OtoSight imaging will not affect patient standard of care.
Interventions
- DEVICE PhotoniCare OtoSight Middle Ear Scope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722770
The ClinicalTrials.gov registry entry for NCT04722770 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoniCare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PhotoniCare OtoSight Middle Ear Scope is the first listed.
NCT04722770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04722770 about?
NCT04722770 is a clinical study titled "Clinical Development of Deep Learning for the OtoSight". The objective of this study is to clinically develop and evaluate a machine learning approach to improve the performance and data interpretation of the PhotoniCare OtoSight Middle Ear Scope in pediatric patients presenting at the primary care office for suspected ear infections. In this observationa...
What is the current status of trial NCT04722770?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2021-01-19. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04722770?
The interventions under investigation include: PhotoniCare OtoSight Middle Ear Scope (DEVICE).
Who is sponsoring clinical trial NCT04722770?
This trial is sponsored by PhotoniCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.